{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:42:43Z","timestamp":1793716963062,"version":"4.6.1"},"reference-count":181,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med. Technol."],"abstract":"<jats:p>Central nervous system (CNS) infections caused by pathogens such as HIV, Herpes simplex virus, Cryptococcus neoformans, and Toxoplasma gondii remain among the most difficult to treat due to the physiological barrier posed by the blood-brain barrier (BBB), pathogen latency, and systemic toxicity associated with conventional therapies. Exosome-based delivery systems are becoming a game-changing platform that can solve these therapeutic problems using their natural biocompatibility, minimal immunogenicity, and capacity to cross the BBB. This review current developments in exosome engineering that aim to make brain-targeted therapy for neuroinfectious illnesses more selective and effective. Much focus is on new molecular methods like pathogen-specific ligand display, aptamer conjugation, lipid modification, and click\u2013chemistry\u2013based surface functionalisation. These methods make it possible to target diseased areas of the brain precisely. Exosomes can also carry therapeutic payloads, such as anti-viral and antifungal drugs, gene editing tools like CRISPR\/Cas9 and siRNA, and more. This makes them helpful in changing pathogens' persistence and the host's immunological responses. The paper tackle problems with translation, such as biodistribution, immunogenicity, GMP production, and regulatory issues. Future possibilities like synthetic exosomes, combinatory medicines, and delivery design that uses AI. The combination of nanotechnology, molecular biology, and infectious disease therapies shows that exosome engineering offers a new way to meet the clinical needs that are not satisfied in treating CNS infections.<\/jats:p>","DOI":"10.3389\/fmedt.2025.1655471","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:35:21Z","timestamp":1759383321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Exosome engineering for targeted therapy of brain-infecting pathogens: molecular tools, delivery platforms, and translational advances"],"prefix":"10.3389","volume":"7","author":[{"given":"Hope","family":"Onohuean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarad Pawar","family":"Naik Bukke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrashekar","family":"Thalluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasim Sakran","family":"Abass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya Essop","family":"Choonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s11684-021-0865-2","article-title":"Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1024004","DOI":"10.3389\/fneur.2022.1024004","article-title":"Epidemiology of neurodegenerative diseases in the east African region: a meta-analysis","volume":"13","author":"Onohuean","year":"2022","journal-title":"Front Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","article-title":"The blood\u2013brain barrier in systemic infection and inflammation","volume":"18","author":"Galea","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1042\/BST20220830","article-title":"The role of the blood\u2013brain barrier during neurological disease and infection","volume":"51","author":"Patabendige","year":"2023","journal-title":"Biochem Soc Trans"},{"key":"B5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12951-025-03352-8","article-title":"Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies","volume":"23","author":"Mehdizadeh","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"839790","DOI":"10.3389\/fphar.2022.839790","article-title":"Challenges in the development of drug delivery systems based on small extracellular vesicles for therapy of brain diseases","volume":"13","author":"Loch-Neckel","year":"2022","journal-title":"Front Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3390\/biom14121519","article-title":"Exosomes in central nervous system diseases: a comprehensive review of emerging research and clinical frontiers","volume":"14","author":"Li","year":"2024","journal-title":"Biomolecules"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.3390\/ijms26073137","article-title":"Engineering exosomes for CNS disorders: advances, challenges, and therapeutic potential","volume":"26","author":"Lee","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"12402","DOI":"10.1039\/D4RA08604J","article-title":"Herbal bioactive-loaded biopolymeric formulations for wound healing applications","volume":"15","author":"Jangra","year":"2025","journal-title":"RSC Adv"},{"key":"B11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12951-023-01952-w","article-title":"Current and prospective strategies for advancing the targeted delivery of CRISPR\/cas system via extracellular vesicles","volume":"21","author":"Huang","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4149\/av_2018_102","article-title":"Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system","volume":"62","author":"Al-Obaidi","year":"2018","journal-title":"Acta Virol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1073\/pnas.1614777114","article-title":"Disrupting the blood\u2013brain barrier by focused ultrasound induces sterile inflammation","volume":"114","author":"Kovacs","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2004025","DOI":"10.1002\/advs.202004025","article-title":"Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization, and drug release","volume":"8","author":"Ruan","year":"2021","journal-title":"Adv Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e01782-19","DOI":"10.1128\/JVI.01782-19","article-title":"Human immunodeficiency virus-associated exosomes promote kaposi\u2019s sarcoma-associated herpesvirus infection via the epidermal growth factor receptor","volume":"94","author":"Chen","year":"2020","journal-title":"J Virol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1479272","DOI":"10.3389\/fneur.2024.1479272","article-title":"Bridging brain and blood: a prospective view on neuroimaging-exosome correlations in HIV-associated neurocognitive disorders","volume":"15","author":"Luo","year":"2025","journal-title":"Front Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/07853890.2020.1814962","article-title":"Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis","volume":"53","author":"Borrajo","year":"2021","journal-title":"Ann Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e02357-20","DOI":"10.1128\/JVI.02357-20","article-title":"Diverse populations of extracellular vesicles with opposite functions during herpes simplex virus 1 infection","volume":"95","author":"Dogrammatzis","year":"2021","journal-title":"J Virol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/cells13141208","article-title":"HSV-1 and cellular miRNAs in CSF-derived exosomes as diagnostically relevant biomarkers for neuroinflammation","volume":"13","author":"Scheiber","year":"2024","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1055\/s-0039-1687837","article-title":"Herpesvirus infections of the central nervous system","volume":"39","author":"Bharucha","year":"2019","journal-title":"Semin Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1572520","DOI":"10.3389\/fcimb.2025.1572520","article-title":"Virulence factors released by extracellular vesicles from cryptococcus neoformans","volume":"15","author":"Xiao","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12883-024-03742-9","article-title":"Severe CSF immune cell alterations in cryptococcal meningitis gradually resolve during antifungal therapy","volume":"24","author":"Dambietz","year":"2024","journal-title":"BMC Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"12421","DOI":"10.2147\/IJN.S483626","article-title":"Toxoplasma gondii-derived exosomes: a potential immunostimulant and delivery system for tumor immunotherapy superior to toxoplasma gondii","volume":"19","author":"Zhao","year":"2024","journal-title":"Int J Nanomed"},{"key":"B24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jacbts.2021.10.017","article-title":"HIV, combination antiretroviral therapy, and vascular diseases in men and women","volume":"7","author":"Kovacs","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e80775","DOI":"10.7554\/eLife.80775","article-title":"Meningeal lymphatic drainage promotes T cell responses against toxoplasma gondii but is dispensable for parasite control in the brain","volume":"11","author":"Kovacs","year":"2022","journal-title":"eLife"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1007\/s12035-023-03365-0","article-title":"Exosomes: promising delivery tools for overcoming blood-brain barrier and glioblastoma therapy","volume":"60","author":"Khatami","year":"2023","journal-title":"Mol Neurobiol"},{"key":"B27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-981-99-7923-3_10","article-title":"Retinal and choroidal infections and inflammation","volume-title":"Ophthalmic Signs in Practice of Medicine","author":"Gupta","year":"2023"},{"key":"B28","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/pharmaceutics14030672","article-title":"Strategies for targeted delivery of exosomes to the brain: advantages and challenges","volume":"14","author":"Choi","year":"2022","journal-title":"Pharmaceutics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/molecules25010003","article-title":"Aptamers chemistry: chemical modifications and conjugation strategies","volume":"25","author":"Odeh","year":"2019","journal-title":"Molecules"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1021\/acs.bioconjchem.5b00291","article-title":"Aptamer\u2013drug conjugates","volume":"26","author":"Zhu","year":"2015","journal-title":"Bioconjugate Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12967-022-03493-6","article-title":"Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases","volume":"20","author":"Fan","year":"2022","journal-title":"J Transl Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12929-024-01055-0","article-title":"Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials","volume":"31","author":"Chen","year":"2024","journal-title":"J Biomed Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-019-0963-9","article-title":"Mechanisms associated with biogenesis of exosomes in cancer","volume":"18","author":"McAndrews","year":"2019","journal-title":"Mol Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3390\/cancers15071992","article-title":"From exosome biogenesis to absorption: key takeaways for cancer research","volume":"15","author":"Lau","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","article-title":"Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp Mol Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/aps.2017.162","article-title":"Exosomes: new molecular targets of diseases","volume":"39","author":"Samanta","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"B37","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"14322","DOI":"10.1038\/s41598-017-14725-x","article-title":"Bioinspired cell-derived nanovesicles versus exosomes as drug delivery systems: a cost-effective alternative","volume":"7","author":"Goh","year":"2017","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12951-018-0403-9","article-title":"Recent advancements in the use of exosomes as drug delivery systems","volume":"16","author":"Bunggulawa","year":"2018","journal-title":"J Nanobiotechnol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijpharm.2018.08.040","article-title":"Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA","volume":"550","author":"Lu","year":"2018","journal-title":"Int J Pharm"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.14336\/AD.2021.0516","article-title":"Extracellular vesicles for the diagnosis and treatment of Parkinson\u2019s disease","volume":"12","author":"Upadhya","year":"2021","journal-title":"Aging Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"109265","DOI":"10.1016\/j.intimp.2022.109265","article-title":"Exosome-based vaccines and their position in next generation vaccines","volume":"113","author":"Negahdaripour","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2306583","DOI":"10.1002\/adma.202306583","article-title":"The landscape of biomimetic nanovesicles in brain diseases","volume":"36","author":"You","year":"2024","journal-title":"Adv Mater"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e10623","DOI":"10.1002\/btm2.10623","article-title":"Micro trojan horses: engineering extracellular vesicles crossing biological barriers for drug delivery","volume":"9","author":"Zeng","year":"2024","journal-title":"Bioeng Transl Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/ATN.ATN-D-24-00025","article-title":"Exosome surface modification and functionalization: a narrative review of emerging technologies and their application potential in precision medicine","volume":"2","author":"Chao","year":"2025","journal-title":"Adv Technol Neurosci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jssc.202100575","article-title":"Current approaches for the purification of antibody-drug conjugates","volume":"45","author":"Matsuda","year":"2022","journal-title":"J Sep Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1021\/acs.jmedchem.0c01530","article-title":"Peptide-drug conjugates with different linkers for cancer therapy","volume":"64","author":"Alas","year":"2021","journal-title":"J Med Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"120268","DOI":"10.1016\/j.ijpharm.2021.120268","article-title":"Antibody-mediated drug delivery","volume":"596","author":"Arslan","year":"2021","journal-title":"Int J Pharm"},{"key":"B49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s42004-024-01255-7","article-title":"Selection of antibody-binding covalent aptamers","volume":"7","author":"Soxpollard","year":"2024","journal-title":"Commun Chem"},{"key":"B50","doi-asserted-by":"publisher","first-page":"889083","DOI":"10.3389\/fchem.2022.889083","article-title":"Chemical conjugation in drug delivery systems","volume":"10","author":"Eras","year":"2022","journal-title":"Front Chem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1039\/d4bm00558a","article-title":"A comprehensive review of engineered exosomes from the preparation strategy to therapeutic applications","volume":"12","author":"Fan","year":"2024","journal-title":"Biomater Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"939441","DOI":"10.3389\/fbioe.2022.939441","article-title":"Research progress in membrane fusion-based hybrid exosomes for drug delivery systems","volume":"10","author":"Liu","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/pharmaceutics15061639","article-title":"Extracellular vesicles and intercellular communication: challenges for in vivo molecular imaging and tracking","volume":"15","author":"Petroni","year":"2023","journal-title":"Pharmaceutics"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1904040","DOI":"10.1002\/adma.201904040","article-title":"Exosomes and nanoengineering: a match made for precision therapeutics","volume":"32","author":"Tran","year":"2020","journal-title":"Adv Mater"},{"key":"B55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12964-025-02268-y","article-title":"Functionalized exosomes for targeted therapy in cancer and regenerative medicine: genetic, chemical, and physical modifications","volume":"23","author":"Gabaran","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","article-title":"Antifungal drug resistance: molecular mechanisms in Candida Albicans and beyond","volume":"121","author":"Lee","year":"2021","journal-title":"Chem Rev"},{"key":"B57","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1021\/acsbiomaterials.4c00856","article-title":"Engineering approaches for exosome cargo loading and targeted delivery: biological versus chemical perspectives","volume":"10","author":"Ahmed","year":"2024","journal-title":"ACS Biomater Sci Eng"},{"key":"B58","doi-asserted-by":"publisher","first-page":"143530","DOI":"10.1016\/j.ijbiomac.2025.143530","article-title":"SELEX-derived DNA aptamer utilized for sensitive electrochemical biosensing of toxoplasma gondii surface antigen 1","volume":"310","author":"Kanagavalli","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"662944","DOI":"10.3389\/fimmu.2021.662944","article-title":"Intravacuolar pathogens hijack host extracellular vesicle biogenesis to secrete virulence factors","volume":"12","author":"Gioseffi","year":"2021","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1111\/dom.14474","article-title":"Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: an observational study using data from routine care","volume":"23","author":"Fralick","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"100751","DOI":"10.1016\/j.waojou.2023.100751","article-title":"The intriguing possibility of using probiotics in allergen-specific immunotherapy","volume":"16","author":"Furci","year":"2023","journal-title":"World Allergy Organ J"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3390\/genes12081244","article-title":"Genetic evaluation of inpatient neonatal and infantile congenital heart defects: new findings and review of the literature","volume":"12","author":"Helm","year":"2021","journal-title":"Genes (Basel)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e2101090","DOI":"10.1002\/advs.202101090","article-title":"Development of novel therapeutics targeting the blood-brain barrier: from barrier to carrier","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.3389\/fmicb.2018.02182","article-title":"Pathogen-Derived extracellular vesicle-associated molecules that affect the host immune system: an overview","volume":"9","author":"Kuipers","year":"2018","journal-title":"Front Microbiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ddc4020019","article-title":"Engineered exosomes as smart drug carriers: overcoming biological barriers in CNS and cancer therapy","volume":"4","author":"Premchandani","year":"2025","journal-title":"Drugs Drug Candidates"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s11033-025-10639-4","article-title":"Precision exosome engineering for neurological therapeutics: molecular mechanisms and targeted strategies","volume":"52","author":"Sharma","year":"2025","journal-title":"Mol Biol Rep"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e12255","DOI":"10.1002\/jev2.12255","article-title":"Specific anti-glioma targeted-delivery strategy of engineered small extracellular vesicles dual-functionalised by Angiopep-2 and TAT peptides","volume":"11","author":"Zhu","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"B69","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12951-025-03415-w","article-title":"Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood-brain barrier permeability","volume":"23","author":"Liu","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13578-021-00650-0","article-title":"Exosomal delivery of therapeutic modulators through the blood\u2013brain barrier; promise and pitfalls","volume":"11","author":"Heidarzadeh","year":"2021","journal-title":"Cell Biosci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-022-00359-3","article-title":"Extracellular vesicles through the blood-brain barrier: a review","volume":"19","author":"Ramos-Zald\u00edvar","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1002314","DOI":"10.37349\/etat.2025.1002314","article-title":"The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection","volume":"6","author":"Thomas","year":"2025","journal-title":"Explor Target Antitumor Ther"},{"key":"B73","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jconrel.2025.01.033","article-title":"Biomimetic exosome harnessing exosomal lipidomics and functional proteins for PEDF-pDNA delivery in high altitude pulmonary edema intervention","volume":"379","author":"Li","year":"2025","journal-title":"J Controlled Release"},{"key":"B74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/pharmaceutics17010109","article-title":"Targeting brain drug delivery with macromolecules through receptor-mediated transcytosis","volume":"17","author":"Li","year":"2025","journal-title":"Pharmaceutics"},{"key":"B75","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/978-3-031-81991-9_19","article-title":"Drug delivery to the brain using endocytic receptors as carriers.","volume-title":"Neuroreceptor Endocytosis and Signaling in Health and Disease","author":"Talwar","year":"2025"},{"key":"B76","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/pharmaceutics16070849","article-title":"An overview on the physiopathology of the blood-brain barrier and the lipid-based nanocarriers for central nervous system delivery","volume":"16","author":"Susa","year":"2024","journal-title":"Pharmaceutics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1080\/1061186X.2021.1929257","article-title":"Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer\u2019s disease","volume":"29","author":"Yu","year":"2021","journal-title":"J Drug Targeting"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1324216","DOI":"10.3389\/fneur.2023.1324216","article-title":"Navigating the brain: the role of exosomal shuttles in precision therapeutics","volume":"14","author":"Fatima","year":"2024","journal-title":"Front Neurol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2478\/arsm-2024-0002","article-title":"Considerations over cerebral toxoplasmosis and other cerebral disorders in HIV-infected patients","volume":"30","author":"Istrate","year":"2024","journal-title":"ARS Medica Tomitana"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/cid\/ciae463","article-title":"Does \u2018Toxoplasma Abscess\u2019 properly describe brain lesions caused by Toxoplasma Gondii?","volume":"80","author":"Vidal","year":"2025","journal-title":"Clin Infect Dis"},{"key":"B81","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/20477724.2022.2083977","article-title":"Cerebral toxoplasmosis in HIV-infected patients: a review","volume":"117","author":"Dian","year":"2023","journal-title":"Pathog Glob Health"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1590\/s1678-9946202466015","article-title":"Calcified cerebral toxoplasmosis associated with recurrent perilesional edema causing neurological manifestations in an HIV-infected individual: case report with a decade-long follow-up","volume":"66","author":"Bonato","year":"2024","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"B83","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11060-023-04257-y","article-title":"T7 peptide-decorated exosome-based nanocarrier system for delivery of galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma","volume":"162","author":"Li","year":"2023","journal-title":"J Neuro-Oncol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41586-024-07948-2","article-title":"Designed endocytosis-inducing proteins degrade targets and amplify signals","volume":"638","author":"Huang","year":"2025","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1021\/acs.molpharmaceut.4c00447","article-title":"Research progress on the strategies for crossing the blood\u2013brain barrier","volume":"21","author":"Qiao","year":"2024","journal-title":"Mol Pharm"},{"key":"B86","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1016\/j.cell.2024.05.039","article-title":"Pan-Cancer proteogenomics expands the landscape of therapeutic targets","volume":"187","author":"Savage","year":"2024","journal-title":"Cell"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-025-01881-1","article-title":"Nanoparticle-based approaches for vascular inflammation in managing hypertension: advancing molecular mechanisms and treatment strategies","author":"KP","year":"2025","journal-title":"Drug Deliv Transl Res"},{"key":"B88","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-97-5536-3_5","article-title":"Technologies for EV surface modification and its application in targeted therapy","volume-title":"Extracellular Vesicle: Biology and Translational Application","author":"Geng","year":"2024"},{"key":"B89","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/biof.2001","article-title":"Advances in screening, synthesis, modification, and biomedical applications of peptides and peptide aptamers","volume":"50","author":"Liu","year":"2024","journal-title":"BioFactors"},{"key":"B90","doi-asserted-by":"publisher","first-page":"135826","DOI":"10.1016\/j.ijbiomac.2024.135826","article-title":"Present and future use of exosomes containing proteins and RNAs in neurodegenerative diseases for synaptic function regulation: a comprehensive review","volume":"280","author":"Liu","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"eadj6251","DOI":"10.1126\/sciadv.adj6251","article-title":"Enhancing the safety of CAR-T cell therapy: synthetic genetic switch for spatiotemporal control","volume":"10","author":"Lu","year":"2024","journal-title":"Sci Adv"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1007\/s12033-023-00932-7","article-title":"Exosomes for CRISPR-Cas9 delivery: the cutting edge in genome editing","volume":"66","author":"Aslan","year":"2024","journal-title":"Mol Biotechnol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3864\/j.issn.0578-1752.2024.13.015","article-title":"Research progress of ApiAP2 transcription factors in regulating the growth and development of Toxoplasma Gondii","volume":"57","author":"Hu","year":"2024","journal-title":"Sci Agric Sin"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e20240005","DOI":"10.1002\/SMMD.20240005","article-title":"Engineering strategies for apoptotic bodies","volume":"3","author":"Hu","year":"2024","journal-title":"Smart Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"105976","DOI":"10.1016\/j.neuint.2025.105976","article-title":"Mechanism of tau protein incorporation into exosomes via cooperative recognition of KFERQ-like motifs by LAMP2A and HSP70","volume":"186","author":"Xu","year":"2025","journal-title":"Neurochem Int"},{"key":"B96","doi-asserted-by":"publisher","first-page":"114784","DOI":"10.1016\/j.expneurol.2024.114784","article-title":"Exosomes derived from vMIP-II-Lamp2b gene-modified M2 cells provide neuroprotection by targeting the injured spinal cord, inhibiting chemokine signals and modulating microglia\/macrophage polarization in mice","volume":"377","author":"Fu","year":"2024","journal-title":"Exp Neurol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1021\/acs.bioconjchem.0c00216","article-title":"In situ one-step fluorescence labeling strategy of exosomes via bioorthogonal click chemistry for real-time exosome tracking in vitro and in vivo","volume":"31","author":"Song","year":"2020","journal-title":"Bioconjugate Chem"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2381891","DOI":"10.1080\/19420862.2024.2381891","article-title":"Discovery and development of ANV419, an IL-2\/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy","volume":"16","author":"Murer","year":"2024","journal-title":"mAbs"},{"key":"B99","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/scipharm93010012","article-title":"Exploring cannabidiol\u2019s therapeutic role in colorectal cancer: network pharmacology and molecular docking insights","volume":"93","author":"Guzm\u00e1n-Flores","year":"2025","journal-title":"Sci Pharm"},{"key":"B100","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/jfb16040148","article-title":"Sorafenib\u2014drug delivery strategies in primary liver cancer","volume":"16","author":"Szyk","year":"2025","journal-title":"J Funct Biomater"},{"key":"B101","doi-asserted-by":"publisher","first-page":"10583","DOI":"10.1039\/D5RA01196E","article-title":"Signature of click chemistry in advanced techniques for cancer therapeutics","volume":"15","author":"Ragab","year":"2025","journal-title":"RSC Adv"},{"key":"B102","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1021\/acsabm.4c00890","article-title":"Correction to \u2018Standardized method to functionalize plasma-extracellular vesicles via copper-free click chemistry for targeted drug delivery strategies\u2019","volume":"7","author":"Ciferri","year":"2024","journal-title":"ACS Appl Bio Mater"},{"key":"B103","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2174\/1567201820666230712103942","article-title":"Engineered exosomes for drug delivery in cancer therapy: a PromisingApproach and application","volume":"21","author":"Fu","year":"2024","journal-title":"Curr Drug Delivery"},{"key":"B104","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12951-024-02298-7","article-title":"Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application","volume":"22","author":"Yang","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3390\/cancers16040823","article-title":"Exosomes in glioma: unraveling their roles in progression, diagnosis, and therapy","volume":"16","author":"Yang","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/23744235.2023.2298450","article-title":"Eliminating the HIV tissue reservoir: current strategies and challenges","volume":"56","author":"Li","year":"2024","journal-title":"Infect Dis"},{"key":"B107","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12967-024-04981-7","article-title":"Engineered bone marrow mesenchymal stem cell-derived exosomes loaded with miR302 through the cardiomyocyte specific peptide can reduce myocardial ischemia and reperfusion (I\/R) injury","volume":"22","author":"Gu","year":"2024","journal-title":"J Transl Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1002\/ctd2.335","article-title":"Signature of click chemistry in exosome modification for cancer therapeutic","volume":"4","author":"Mukerjee","year":"2024","journal-title":"Clin Transl Discov"},{"key":"B109","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1039\/D4NA00501E","article-title":"A comprehensive review of challenges and advances in exosome-based drug delivery systems","volume":"6","author":"Palakurthi","year":"2024","journal-title":"Nanoscale Adv"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1502155","DOI":"10.3389\/fbioe.2024.1502155","article-title":"Innovative approaches in lung tissue engineering: the role of exosome-loaded bioscaffolds in regenerative medicine","volume":"12","author":"Torkashvand","year":"2024","journal-title":"Front Bioeng Biotechnol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2400551","DOI":"10.1002\/smtd.202400551","article-title":"Empowering exosomes with aptamers for precision theranostics","author":"Zheng","year":"2024","journal-title":"Small Methods"},{"key":"B112","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s13530-019-0392-6","article-title":"The role of aptamer loaded exosome complexes in the neurodegenerative diseases","volume":"11","author":"Sekhon","year":"2019","journal-title":"J Toxicol Environ Health Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1021\/acscentsci.4c00563","article-title":"Delivering DNA aptamers across the blood\u2013brain barrier reveals heterogeneous decreased ATP in different brain regions of Alzheimer\u2019s disease mouse models","volume":"10","author":"Banik","year":"2024","journal-title":"ACS Cent Sci"},{"key":"B114","doi-asserted-by":"publisher","first-page":"123403","DOI":"10.1016\/j.biomaterials.2025.123403","article-title":"Multi-targeted engineered hybrid exosomes as a\u03b2 nanoscavengers and inflammatory modulators for multi-pathway intervention in Alzheimer\u2019s disease","volume":"322","author":"Du","year":"2025","journal-title":"Biomaterials"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1039\/D5BM00179J","article-title":"Biofunctionalized nanomaterials for Parkinson\u2019s disease theranostics: potential for efficient PD biomarker detection and effective therapy","volume":"13","author":"Sabnam","year":"2025","journal-title":"Biomater Sci"},{"key":"B116","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1039\/D4NR00207E","article-title":"Role of aptamer technology in extracellular vesicle biology and therapeutic applications","volume":"16","author":"Chowdhury","year":"2024","journal-title":"Nanoscale"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1021\/acs.bioconjchem.5c00022","article-title":"Targeting HER2 with DNA aptamers for efficient anticancer drug delivery: a combined experimental and computational study","volume":"36","author":"Katsuba","year":"2025","journal-title":"Bioconjugate Chem"},{"key":"B118","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s42452-025-07010-4","article-title":"Immunomodulatory potentials of Andrographis Paniculata and Allium Sativum in managing plasmodium infections","volume":"7","author":"Atwijukire","year":"2025","journal-title":"Discov Appl Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"26838","DOI":"10.1021\/acsomega.4c02466","article-title":"Computational frontiers in aptamer-based nanomedicine for precision therapeutics: a comprehensive review","volume":"9","author":"Kumar","year":"2024","journal-title":"ACS Omega"},{"key":"B120","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15212\/bioi-2024-0002","article-title":"Aptamer-based theranostics in oncology: design strategies and limitations","volume":"5","author":"Trivedi","year":"2024","journal-title":"BIO Integration"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e13717","DOI":"10.1002\/jcsm.13717","article-title":"Aptamer-conjugated exosomes ameliorate diabetes-induced muscle atrophy by enhancing SIRT1\/FoxO1\/3a-mediated mitochondrial function","volume":"16","author":"Song","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s41401-022-00902-w","article-title":"Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy","volume":"43","author":"Mukherjee","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"B123","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.2147\/IJN.S464249","article-title":"Engineering exosomes for therapeutic applications: decoding biogenesis, content modification, and cargo loading strategies","volume":"19","author":"Bahadorani","year":"2024","journal-title":"Int J Nanomed"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1100892","DOI":"10.3389\/fbioe.2022.1100892","article-title":"Recent developments in isolating methods for exosomes","volume":"10","author":"Gao","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"100053","DOI":"10.1016\/j.vesic.2024.100053","article-title":"Extracellular vesicle-based drug delivery systems in cancer","volume":"4","author":"Huang","year":"2024","journal-title":"Extracell Vesicle"},{"key":"B126","doi-asserted-by":"publisher","first-page":"8278","DOI":"10.1038\/s41598-019-44569-6","article-title":"Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood\u2013brain barrier penetration","volume":"9","author":"Khongkow","year":"2019","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1531425","DOI":"10.3389\/fmicb.2025.1531425","article-title":"iPSC-derived exosomes as amphotericin B carriers: a promising approach to combat cryptococcal meningitis","volume":"16","author":"Zhao","year":"2025","journal-title":"Front Microbiol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12951-025-03238-9","article-title":"An anti-CD19-exosome delivery system navigates the blood\u2013brain barrier for targeting of central nervous system lymphoma","volume":"23","author":"Zhao","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/pharmaceutics17091127","article-title":"Therapeutic effect of membrane vesicle drug delivery systems in inflammatory bowel disease","volume":"17","author":"Zhao","year":"2025","journal-title":"Pharmaceutics"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2403199","DOI":"10.1002\/adma.202403199","article-title":"Immunogenicity of extracellular vesicles","volume":"36","author":"Xia","year":"2024","journal-title":"Adv Mater"},{"key":"B131","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1039\/D4CC06501H","article-title":"Engineered extracellular vesicles: an emerging nanomedicine therapeutic platform","volume":"61","author":"Tang","year":"2025","journal-title":"Chem Commun"},{"key":"B132","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1039\/D4TB00565A","article-title":"Advances in biomimetic nanomaterial delivery systems: harnessing nature\u2019s inspiration for targeted drug delivery","volume":"12","author":"Kang","year":"2024","journal-title":"J Mater Chem B"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s13346-024-01710-x","article-title":"Exosome-based drug delivery systems for enhanced neurological therapeutics","volume":"15","author":"Vahab","year":"2025","journal-title":"Drug Deliv Transl Res"},{"key":"B134","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-0-443-13474-6.00016-0","article-title":"Treatment of CNS infections in AIDS positive patients through novel drug delivery systems","volume-title":"Novel Drug Delivery Systems in the Management of CNS Disorders","author":"Pancholi","year":"2025"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/infdis\/jiae308","article-title":"Dolutegravir- versus efavirenz-based treatment in pregnancy: impact on red blood cell folate concentrations in pregnant women and their infants","volume":"230","author":"Jacobson","year":"2024","journal-title":"J Infect Dis"},{"key":"B136","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00203-023-03744-0","article-title":"Exploring therapeutic avenues: mesenchymal stem\/stromal cells and exosomes in confronting enigmatic biofilm-producing fungi","volume":"206","author":"Bicer","year":"2024","journal-title":"Arch Microbiol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1007\/s00210-024-03702-7","article-title":"Exosomes in infectious diseases: insights into leishmaniasis pathogenesis, immune modulation, and therapeutic potential","volume":"398","author":"Abida","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3390\/microorganisms12112324","article-title":"Sclareolide as antifungal strategy against cryptococcus neoformans: unveiling its mechanisms of action","volume":"12","author":"Ganeshkumar","year":"2024","journal-title":"Microorganisms"},{"key":"B139","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.jpha.2024.101084","article-title":"Exploration of innovative drug repurposing strategies for combating human protozoan diseases: advances, challenges, and opportunities","volume":"15","author":"Hu","year":"2025","journal-title":"J Pharm Anal"},{"key":"B140","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/13543776.2023.2206017","article-title":"Novel therapeutic opportunities for Toxoplasma Gondii, Trichomonas Vaginalis, and Giardia Intestinalis infections","volume":"33","author":"Arrighi","year":"2023","journal-title":"Expert Opin Ther Pat"},{"key":"B141","doi-asserted-by":"publisher","first-page":"15697","DOI":"10.1038\/s41598-025-98993-y","article-title":"Phytochemical content of cycas rumphii N-butanol fraction and antiprotozoal activity against toxoplasma gondii in vivo","volume":"15","author":"El-Seadawy","year":"2025","journal-title":"Sci Rep"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3389\/fimmu.2020.02021","article-title":"Anti-inflammatory and neuroprotective agents in clinical trials for CNS disease and injury: where do we go from here?","volume":"11","author":"Mallah","year":"2020","journal-title":"Front Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1523\/JNEUROSCI.21-02-00581.2001","article-title":"Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo","volume":"21","author":"Erickson","year":"2001","journal-title":"J Neurosci"},{"key":"B144","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12035-022-03088-8","article-title":"The importance of using exosome-loaded miRNA for the treatment of spinal cord injury","volume":"60","author":"Shen","year":"2023","journal-title":"Mol Neurobiol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1038\/s41380-023-02126-8","article-title":"Recent advances in the role of miRNAs in post-traumatic stress disorder and traumatic brain injury","volume":"28","author":"Zhu","year":"2023","journal-title":"Mol Psychiatry"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/cpt.1328","article-title":"From endogenous compounds as biomarkers to plasma-derived nanovesicles as liquid biopsy; has the golden age of translational pharmacokinetics-absorption, distribution, metabolism, excretion-drug\u2013drug interaction science finally arrived?","volume":"105","author":"Rodrigues","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"B147","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1021\/jacsau.3c00611","article-title":"Extracellular vesicles for drug delivery and theranostics in vivo","volume":"4","author":"Rakshit","year":"2024","journal-title":"JACS Au"},{"key":"B148","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3390\/pharmaceutics15030716","article-title":"Oral administration as a potential alternative for the delivery of small extracellular vesicles","volume":"15","author":"Donoso-Meneses","year":"2023","journal-title":"Pharmaceutics"},{"key":"B149","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.ymthe.2021.10.009","article-title":"sEVsRVG selectively delivers antiviral siRNA to fetus brain, inhibits ZIKV infection and mitigates ZIKV-induced microcephaly in mouse model","volume":"30","author":"Zhang","year":"2022","journal-title":"Mol Ther"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ymthe.2022.10.008","article-title":"Cell-derived nanovesicle-mediated drug delivery to the brain: principles and strategies for vesicle engineering","volume":"31","author":"Liang","year":"2023","journal-title":"Mol Ther"},{"key":"B151","doi-asserted-by":"publisher","first-page":"73","DOI":"10.32607\/actanaturae.27499","article-title":"Intraventricular administration of exosomes from patients with amyotrophic lateral sclerosis provokes motor neuron disease in mice","volume":"16","author":"Stavrovskaya","year":"2024","journal-title":"Acta Naturae"},{"key":"B152","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1089\/cbr.2016.2009","article-title":"Radiolabeling of extracellular vesicles with99m tc for quantitative In Vivo imaging studies","volume":"31","author":"Varga","year":"2016","journal-title":"Cancer Biother Radiopharm"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.bbamem.2018.03.013","article-title":"PKH26 labeling of extracellular vesicles: characterization and cellular internalization of contaminating PKH26 nanoparticles","volume":"1860","author":"Pu\u017ear Dominku\u0161","year":"2018","journal-title":"Biochim Biophys Acta"},{"key":"B154","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-031-64828-1_16","article-title":"Nanoparticles for imaging of lymphatic system: challenges and future perspective","volume-title":"Advanced Targeting of the Lymphatic System","author":"Onohuean","year":"2024"},{"key":"B155","doi-asserted-by":"publisher","first-page":"424","DOI":"10.7150\/ntno.86467","article-title":"Magnetic resonance imaging and iron-oxide nanoparticles in the era of personalized medicine","volume":"7","author":"Rahman","year":"2023","journal-title":"Nanotheranostics"},{"key":"B156","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0165-5728(98)00118-0","article-title":"Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma","volume":"89","author":"Hirschberg","year":"1998","journal-title":"J Neuroimmunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0165-5728(92)90008-9","article-title":"Selective localisation of neuro-specific T lymphocytes in the central nervous system","volume":"37","author":"Ludowyk","year":"1992","journal-title":"J Neuroimmunol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"e13904","DOI":"10.1111\/cts.13904","article-title":"Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes","volume":"17","author":"Wang","year":"2024","journal-title":"Clin Transl Sci"},{"key":"B159","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40259-016-0174-5","article-title":"Assessing the immunogenicity of biopharmaceuticals","volume":"30","author":"Pineda","year":"2016","journal-title":"BioDrugs"},{"key":"B160","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.3390\/jcm14072519","article-title":"The current landscape of clinical trials","volume":"14","author":"Joshi","year":"2025","journal-title":"J Clin Med"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3389\/fmicb.2020.01161","article-title":"Good manufacturing practice (GMP) compliance for phage therapy medicinal products","volume":"11","author":"Bretaudeau","year":"2020","journal-title":"Front Microbiol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.3390\/pharmaceutics15082042","article-title":"Exosome-based drug delivery: translation from bench to clinic","volume":"15","author":"Koh","year":"2023","journal-title":"Pharmaceutics"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3390\/bios12111023","article-title":"Biomedical applications of microfluidic devices: a review","volume":"12","author":"Gharib","year":"2022","journal-title":"Biosensors"},{"key":"B164","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1021\/acsbiomaterials.2c01329","article-title":"Exosome-based smart drug delivery tool for cancer theranostics","volume":"9","author":"Kar","year":"2023","journal-title":"ACS Biomater Sci Eng"},{"key":"B165","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jconrel.2020.10.020","article-title":"Challenges in the development and establishment of exosome-based drug delivery systems","volume":"329","author":"Wang","year":"2021","journal-title":"J Controlled Release"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bioactmat.2024.04.007","article-title":"Hydrogel-exosome system in tissue engineering: a promising therapeutic strategy","volume":"38","author":"Fan","year":"2024","journal-title":"Bioact Mater"},{"key":"B167","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/aps.2017.178","article-title":"Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"B168","article-title":"\u201cBioinspired NeuroPods: AI-Enhanced 4D Composite Bioprinting Revolutionizing Brain-on-Chip and Neural Regeneration.\u201d Preprint, July 23. (2025)","author":"Ayad","year":""},{"key":"B169","doi-asserted-by":"publisher","first-page":"7364","DOI":"10.3390\/ijms26157364","article-title":"Precision neuro-oncology in glioblastoma: aI-guided CRISPR editing and real-time multi-omics for genomic brain surgery","volume":"26","author":"\u0218erban","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B170","doi-asserted-by":"publisher","first-page":"gutjnl-2022-327099","DOI":"10.1136\/gutjnl-2022-327099","article-title":"Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions","volume":"17","author":"Macias","year":"2022","journal-title":"Gut"},{"key":"B171","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bioactmat.2024.11.021","article-title":"AI-driven 3D bioprinting for regenerative medicine: from bench to bedside","volume":"45","author":"Zhang","year":"2025","journal-title":"Bioact Mater"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1007\/s12015-021-10309-5","article-title":"Combination therapy of stem cell-derived exosomes and biomaterials in the wound healing","volume":"18","author":"Golchin","year":"2022","journal-title":"Stem Cell Rev Rep"},{"key":"B173","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-019-1074-3","article-title":"The role of exosomal PD-L1 in tumor progression and immunotherapy","volume":"18","author":"Xie","year":"2019","journal-title":"Mol Cancer"},{"key":"B174","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.drudis.2021.05.008","article-title":"Drug combination therapy for emerging viral diseases","volume":"26","author":"Shyr","year":"2021","journal-title":"Drug Discov Today"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1485769","DOI":"10.3389\/fphar.2025.1485769","article-title":"Exosomes as natural vectors for therapeutic delivery of bioactive compounds in skin diseases","volume":"16","author":"Keshtkar","year":"2025","journal-title":"Front Pharmacol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"100029","DOI":"10.1016\/j.vesic.2023.100029","article-title":"Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes based therapeutics","volume":"2","author":"Cheng","year":"2023","journal-title":"Extracell Vesicle"},{"key":"B177","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.nantod.2023.101771","article-title":"Exosome nanovesicles: a potential carrier for therapeutic delivery","volume":"49","author":"Chavda","year":"2023","journal-title":"Nano Today"},{"key":"B178","doi-asserted-by":"publisher","first-page":"101613","DOI":"10.1016\/j.mtbio.2025.101613","article-title":"Exosome isolation and characterization for advanced diagnostic and therapeutic applications","volume":"31","author":"Mukerjee","year":"2025","journal-title":"Mater Today Bio"},{"key":"B179","doi-asserted-by":"crossref","DOI":"10.1201\/9781003298304","article-title":"Advances in surgical and medical specialties","volume-title":"Current Issues in Medecine","author":"Bawa","year":"2023"},{"key":"B180","doi-asserted-by":"publisher","first-page":"284","DOI":"10.14348\/molcells.2022.2033","article-title":"Manufacturing therapeutic exosomes: from bench to industry","volume":"45","author":"Ahn","year":"2002","journal-title":"Mol Cells"},{"key":"B181","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1111\/ajt.16591","article-title":"T cell antigenicity and immunogenicity of allogeneic exosomes","volume":"21","author":"Prunevieille","year":"2021","journal-title":"Am J Transplant."}],"container-title":["Frontiers in Medical Technology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmedt.2025.1655471\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:35:25Z","timestamp":1759383325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmedt.2025.1655471\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":181,"alternative-id":["10.3389\/fmedt.2025.1655471"],"URL":"https:\/\/doi.org\/10.3389\/fmedt.2025.1655471","relation":{},"ISSN":["2673-3129"],"issn-type":[{"value":"2673-3129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1655471"}}